LAST PRICE - AT THE CLOSE
EMRAF is DOWN -9% since the begininning of the year
EMRAF is UP 2% ABOVE 20 day SMA
EMRAF is DOWN -10% BELOW 200 day SMA
PROFITABLE: YES
EPS: $0.275
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: 10.8923
INCOME TO DEBT RATIO: 0.06
 |
THE STOCK IS 33.0% AWAY FROM ALL-TIME HIGHS OF $52.56 |
 |
EMRAF IS DOWN -9% SINCE THE BEGINNING OF THE YEAR |
 |
EMRAF IS DOWN -8% OVER THE PAST 12 MONTHS |
 |
EMRAF IS UP 7% OVER THE PAST 1 MONTH |
 |
2% OF ALL EMRAF INVESTORS ARE BETTING AGAINST EMRAF |
 |
NUM INVESTORS SHORT EMRAF HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|---|---|
 | New 60 minute low. | 11/28 |
 | Opening range breakd... | 11/28 |
 | 60 minute MACD cross... | 11/28 |
 | 60 minute MACD cross... | 11/28 |
 |
EMRAF moved up 0 in the previous minute |
 |
EMRAF is up 0.03 over the last hour |
 |
EMRAF is up 0.7% over the last 5 days |
 |
EMRAF is 0.4 above its 8 day SMA |
| $35.20 |  DAY |
$35.44 |
| $35.15 |  PREVIOUS DAY |
$35.23 |
| $35.15 | WEEK |
$35.82 |
| $32.59 |  MONTH |
$35.82 |
| $31.85 | YEAR |
$44.13 |
EMRAF is mentioned N/A less than normal on 
EMRAF is mentioned N/A times in an average day on 
